{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:28:37Z","timestamp":1793384917324,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The immune system of patients infected by SARS-CoV-2 is severely impaired. Detailed investigation of T cells and cytokine production in patients affected by COVID-19 pneumonia are urgently required. Here we show that, compared with healthy controls, COVID-19 patients\u2019 T cell compartment displays several alterations involving na\u00efve, central memory, effector memory and terminally differentiated cells, as well as regulatory T cells and PD1\n                    <jats:sup>+<\/jats:sup>\n                    CD57\n                    <jats:sup>+<\/jats:sup>\n                    exhausted T cells. Significant alterations exist also in several lineage-specifying transcription factors and chemokine receptors. Terminally differentiated T cells from patients proliferate less than those from healthy controls, whereas their mitochondria functionality is similar in CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells from both groups. Patients display significant increases of proinflammatory or anti-inflammatory cytokines, including T helper type-1 and type-2 cytokines, chemokines and galectins; their lymphocytes produce more tumor necrosis factor (TNF), interferon-\u03b3, interleukin (IL)-2 and IL-17, with the last observation implying that blocking IL-17 could provide a novel therapeutic strategy for COVID-19.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-17292-4","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T06:03:04Z","timestamp":1594015384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":690,"title":["Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia"],"prefix":"10.1038","volume":"11","author":[{"given":"Sara","family":"De Biasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Meschiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Gibellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Bellinazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Borella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Fidanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licia","family":"Gozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7762-2535","authenticated-orcid":false,"given":"Domenico","family":"Lo Tartaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4235-589X","authenticated-orcid":false,"given":"Marco","family":"Mattioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Paolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Menozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovana","family":"Mili\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Fantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Tonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Sarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Trenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Brugioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cicchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4694-9564","authenticated-orcid":false,"given":"Fabio","family":"Facchinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7411-935X","authenticated-orcid":false,"given":"Antonello","family":"Pietrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1515-5094","authenticated-orcid":false,"given":"Enrico","family":"Clini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Girardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5724-3914","authenticated-orcid":false,"given":"Giovanni","family":"Guaraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mussini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5381-1558","authenticated-orcid":false,"given":"Andrea","family":"Cossarizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"key":"17292_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 382, 1199\u20131207 (2020).","journal-title":"N. Engl. J. Med."},{"key":"17292_CR2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/cyto.a.24002","volume":"97","author":"A Cossarizza","year":"2020","unstructured":"Cossarizza, A. et al. SARS-CoV-2, the virus that causes COVID-19: cytometry and the new challenge for global health. Cytom. A 97, 340\u2013343 (2020).","journal-title":"Cytom. A"},{"key":"17292_CR3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 565\u2013574 (2020).","journal-title":"Lancet"},{"key":"17292_CR4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1056\/NEJMc2001468","volume":"382","author":"C Rothe","year":"2020","unstructured":"Rothe, C. et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N. Engl. J. Med. 382, 10\u201311 (2020).","journal-title":"N. Engl. J. Med."},{"key":"17292_CR5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(03)13967-0","volume":"362","author":"T Kuiken","year":"2003","unstructured":"Kuiken, T. et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362, 263\u2013270 (2003).","journal-title":"Lancet"},{"key":"17292_CR6","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/cid\/ciy595","volume":"68","author":"HS Shin","year":"2019","unstructured":"Shin, H. S. et al. Immune responses to middle east respiratory syndrome coronavirus during the acute and convalescent phases of human infection. Clin. Infect. Dis. 68, 984\u2013992 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"17292_CR7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"17292_CR8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507\u2013513 (2020).","journal-title":"Lancet"},{"key":"17292_CR9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(20)30360-3","volume":"395","author":"H Chen","year":"2020","unstructured":"Chen, H. et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 395, 809\u2013815 (2020).","journal-title":"Lancet"},{"key":"17292_CR10","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/apa.15270","volume":"109","author":"JF Ludvigsson","year":"2020","unstructured":"Ludvigsson, J. F. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 109, 1088\u20131095 (2020).","journal-title":"Acta Paediatr."},{"key":"17292_CR11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0047-6374(95)01691-0","volume":"86","author":"A Cossarizza","year":"1996","unstructured":"Cossarizza, A. et al. CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: implications for T cell memory. Mech. Ageing Dev. 86, 173\u2013195 (1996).","journal-title":"Mech. Ageing Dev."},{"key":"17292_CR12","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(94)91641-1","volume":"344","author":"ML Tang","year":"1994","unstructured":"Tang, M. L. et al. Reduced interferon-gamma secretion in neonates and subsequent atopy. Lancet 344, 983\u2013985 (1994).","journal-title":"Lancet"},{"key":"17292_CR13","doi-asserted-by":"publisher","unstructured":"Guaraldi, G. et al. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol., in press, https:\/\/doi.org\/10.1016\/S2665-9913(20)30173-9 (2020).","DOI":"10.1016\/S2665-9913(20)30173-9"},{"key":"17292_CR14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen, S. et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytom. A 87, 636\u2013645 (2015).","journal-title":"Cytom. A"},{"key":"17292_CR15","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/eji.201343751","volume":"43","author":"YD Mahnke","year":"2013","unstructured":"Mahnke, Y. D. et al. The who\u2019s who of T-cell differentiation: human memory T-cell subsets. Eur. J. Immunol. 43, 2797\u20132809 (2013).","journal-title":"Eur. J. Immunol."},{"key":"17292_CR16","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","volume":"17","author":"L Gattinoni","year":"2011","unstructured":"Gattinoni, L. et al. A human memory T cell subset with stem cell-like properties. Nat. Med. 17, 1290\u20131297 (2011).","journal-title":"Nat. Med."},{"key":"17292_CR17","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1182\/blood-2011-02-334698","volume":"118","author":"CJ Turtle","year":"2011","unstructured":"Turtle, C. J. et al. Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8\u03b1+ semi-invariant T cells. Blood 118, 2752\u20132762 (2011).","journal-title":"Blood"},{"key":"17292_CR18","doi-asserted-by":"publisher","unstructured":"Cossarizza, A. et al. Handling and processing of blood specimens from patients with COVID-19 for safe studies on cell phenotype and cytokine storm. Cytometry A, https:\/\/doi.org\/10.1002\/cyto.a.24009 (2020, in press).","DOI":"10.1002\/cyto.a.24009"},{"key":"17292_CR19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.a.21015","volume":"79","author":"M Roederer","year":"2011","unstructured":"Roederer, M. et al. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytom. A 79, 167\u2013174 (2011).","journal-title":"Cytom. A"},{"key":"17292_CR20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41591-020-0819-2","volume":"26","author":"I Thevarajan","year":"2020","unstructured":"Thevarajan, I. et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat. Med. 26, 453\u2013455 (2020).","journal-title":"Nat. Med."},{"key":"17292_CR21","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/mi.2016.116","volume":"10","author":"CS McGary","year":"2017","unstructured":"McGary, C. S. et al. The loss of CCR6+ and CD161+ CD4+ T-cell homeostasis contributes to disease progression in SIV-infected rhesus macaques. Mucosal Immunol. 10, 1082\u20131096 (2017).","journal-title":"Mucosal Immunol."},{"key":"17292_CR22","doi-asserted-by":"crossref","first-page":"e0157407","DOI":"10.1371\/journal.pone.0157407","volume":"11","author":"N Rout","year":"2016","unstructured":"Rout, N. Enhanced Th1\/Th17 functions of CD161+ CD8+ T cells in mucosal tissues of rhesus macaques. PLoS ONE 11, e0157407 (2016).","journal-title":"PLoS ONE"},{"key":"17292_CR23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","volume":"17","author":"M Zheng","year":"2020","unstructured":"Zheng, M. et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell. Mol. Immunol. 17, 533\u2013535 (2020).","journal-title":"Cell. Mol. Immunol."},{"key":"17292_CR24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","volume":"17","author":"H Zheng","year":"2020","unstructured":"Zheng, H. et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell. Mol. Immunol. 17, 541\u2013543 (2020).","journal-title":"Cell. Mol. Immunol."},{"key":"17292_CR25","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen, G. et al. Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. J. Clin. Investig. 130, 2620\u20132629 (2020).","journal-title":"J. Clin. Investig."},{"key":"17292_CR26","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","volume":"221","author":"F Wang","year":"2020","unstructured":"Wang, F. et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J. Infect. Dis. 221, 1762\u20131769 (2020).","journal-title":"J. Infect. Dis."},{"key":"17292_CR27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nri1029","volume":"3","author":"MG von Herrath","year":"2003","unstructured":"von Herrath, M. G. & Harrison, L. C. Antigen-induced regulatory T cells in autoimmunity. Nat. Rev. Immunol. 3, 223\u2013232 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"17292_CR28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.it.2006.10.002","volume":"27","author":"AH Banham","year":"2006","unstructured":"Banham, A. H. Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells. Trends Immunol. 27, 541\u2013544 (2006).","journal-title":"Trends Immunol."},{"key":"17292_CR29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ni1428","volume":"8","author":"JM Kim","year":"2007","unstructured":"Kim, J. M. et al. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191\u2013197 (2007).","journal-title":"Nat. Immunol."},{"key":"17292_CR30","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","volume":"110","author":"G Borsellino","year":"2007","unstructured":"Borsellino, G. et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110, 1225\u20131232 (2007).","journal-title":"Blood"},{"key":"17292_CR31","doi-asserted-by":"crossref","first-page":"6780","DOI":"10.4049\/jimmunol.177.10.6780","volume":"177","author":"JJ Kobie","year":"2006","unstructured":"Kobie, J. J. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5\u2019-adenosine monophosphate to adenosine. J. Immunol. 177, 6780\u20136786 (2006).","journal-title":"J. Immunol."},{"key":"17292_CR32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi, S. Regulatory T cells and immune tolerance. Cell 133, 775\u2013787 (2008).","journal-title":"Cell"},{"key":"17292_CR33","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/eji.201546178","volume":"46","author":"M Pinti","year":"2016","unstructured":"Pinti, M. et al. Aging of the immune system: focus on inflammation and vaccination. Eur. J. Immunol. 46, 2286\u20132301 (2016).","journal-title":"Eur. J. Immunol."},{"key":"17292_CR34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1189\/jlb.0809566","volume":"87","author":"D Focosi","year":"2010","unstructured":"Focosi, D. CD57+ T lymphocytes and functional immune deficiency. J. Leukoc. Biol. 87, 107\u2013116 (2010).","journal-title":"J. Leukoc. Biol."},{"key":"17292_CR35","first-page":"75","volume":"410","author":"K Chamoto","year":"2017","unstructured":"Chamoto, K. Role of PD-1 in immunity and diseases. Curr. Top. Microbiol. Immunol. 410, 75\u201397 (2017).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"17292_CR36","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1373\/clinchem.2005.054460","volume":"51","author":"NL Tang","year":"2005","unstructured":"Tang, N. L. et al. Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome. Clin. Chem. 51, 2333\u20132340 (2005).","journal-title":"Clin. Chem."},{"key":"17292_CR37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","volume":"136","author":"CK Wong","year":"2004","unstructured":"Wong, C. K. et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin. Exp. Immunol. 136, 95\u2013103 (2004).","journal-title":"Clin. Exp. Immunol."},{"key":"17292_CR38","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1128\/JVI.79.12.7819-7826.2005","volume":"79","author":"CY Cheung","year":"2005","unstructured":"Cheung, C. Y. et al. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J. Virol. 79, 7819\u20137826 (2005).","journal-title":"J. Virol."},{"key":"17292_CR39","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2004-10-4166","volume":"106","author":"HK Law","year":"2005","unstructured":"Law, H. K. et al. Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood 106, 2366\u20132374 (2005).","journal-title":"Blood"},{"key":"17292_CR40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cyto.2018.01.025","volume":"104","author":"WH Mahallawi","year":"2018","unstructured":"Mahallawi, W. H. et al. MERS-CoV infection in humans is associated with a proinflammatory Th1 and Th17 cytokine profile. Cytokine 104, 8\u201313 (2018).","journal-title":"Cytokine"},{"key":"17292_CR41","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/cid\/ciy595","volume":"68","author":"HS Shin","year":"2019","unstructured":"Shin, H. S. et al. Immune responses to Middle East Respiratory Syndrome coronavirus during the acute and convalescent phases of human infection. Clin. Infect. Dis. 68, 984\u2013992 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"17292_CR42","doi-asserted-by":"publisher","unstructured":"Bordoni, V. et al. An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19. Clin. Infect. Dis., https:\/\/doi.org\/10.1093\/cid\/ciaa577 (2020).","DOI":"10.1093\/cid\/ciaa577"},{"key":"17292_CR43","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/1744666X.2014.894886","volume":"10","author":"RC Russo","year":"2014","unstructured":"Russo, R. C. et al. The CXCL8\/IL-8 chemokine family and its receptors in inflammatory diseases. Expert Rev. Clin. Immunol. 10, 593\u2013619 (2014).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"17292_CR44","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.4049\/jimmunol.1900235","volume":"202","author":"C Dahlgren","year":"2019","unstructured":"Dahlgren, C. et al. Intracellular neutrophil oxidants: from laboratory curiosity to clinical reality. J. Immunol. 202, 3127\u20133134 (2019).","journal-title":"J. Immunol."},{"key":"17292_CR45","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss, R. S. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13, 862\u2013874 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"17292_CR46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-immunol-041015-055402","volume":"34","author":"S Thiemann","year":"2016","unstructured":"Thiemann, S. & Baum, L. G. Galectins and immune responses-just how do they do those things they do? Annu. Rev. Immunol. 34, 243\u2013264 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"17292_CR47","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.4049\/jimmunol.1701172","volume":"199","author":"V Sundblad","year":"2017","unstructured":"Sundblad, V. et al. Galectin-1: a Jack-of-All-Trades in the resolution of acute and chronic inflammation. J. Immunol. 199, 3721\u20133730 (2017).","journal-title":"J. Immunol."},{"key":"17292_CR48","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00002030-199709000-00001","volume":"11","author":"A Cossarizza","year":"1997","unstructured":"Cossarizza, A. T-cell repertoire and HIV infection: facts and perspectives. AIDS 11, 1075\u20131088 (1997).","journal-title":"AIDS"},{"key":"17292_CR49","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","volume":"55","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality [2020]. Int. J. Antimicrob. Agents, 55, 105954 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"17292_CR50","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/eji.201970107","volume":"49","author":"A Cossarizza","year":"2019","unstructured":"Cossarizza, A. et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies. (second edition). Eur. J. Immunol. 49, 1457\u20131973 (2019).","journal-title":"Eur. J. Immunol."},{"key":"17292_CR51","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/nprot.2006.268","volume":"1","author":"L Lamoreaux","year":"2006","unstructured":"Lamoreaux, L. et al. Intracellular cytokine optimization and standard operating procedure. Nat. Protoc. 1, 1507\u20131516 (2006).","journal-title":"Nat. Protoc."},{"key":"17292_CR52","doi-asserted-by":"publisher","first-page":"748","DOI":"10.12688\/f1000research.11622.4","volume":"6","author":"M Nowicka","year":"2019","unstructured":"Nowicka, M. et al. CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets. F1000Research 6, 748, https:\/\/doi.org\/10.12688\/f1000research.11622.4 (2019).","journal-title":"F1000Research"},{"key":"17292_CR53","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/eji.201948223","volume":"49","author":"S De Biasi","year":"2019","unstructured":"De Biasi, S. et al. Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients. Eur. J. Immunol. 49, 2204\u20132221 (2019).","journal-title":"Eur. J. Immunol."},{"key":"17292_CR54","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s42003-019-0415-5","volume":"2","author":"LM Weber","year":"2019","unstructured":"Weber, L. M. et al. Diffcyt: differential discovery in high-dimensional cytometry via high-resolution clustering. Commun. Biol. 2, 183 (2019).","journal-title":"Commun. Biol."},{"key":"17292_CR55","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/cyto.a.22106","volume":"81","author":"J Spidlen","year":"2012","unstructured":"Spidlen, J. et al. FlowRepository - a resource of annotated flow cytometry datasets associated with peer-reviewed publications. Cytom. A 81, 727\u2013731 (2012).","journal-title":"Cytom. A"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17292-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17292-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17292-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T19:06:11Z","timestamp":1670267171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17292-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["17292"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-17292-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-23957\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,6]]},"assertion":[{"value":"24 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3434"}}